PUBLIC CONTRACT · 2024
propOFol 10 mg/ml Emul inj Fr, ROpivacaína 7.5 mg/ml Sol in, Linezolida 600 mg/300 ml Sol in, Sugamadex 100 mg/ml Sol inj
- Contract value
- €3,602.28
- Signed on
- 12 March 2024
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10686057PUBLISHED DESCRIPTION
1158924 - propOFol 10 mg/ml Emul inj Fr, ROpivacaína 7.5 mg/ml Sol in, Linezolida 600 mg/300 ml Sol in, Sugamadex 100 mg/ml Sol inj
Parties involved
- Place of performance
- Portugal, Porto, Porto
- NUTS region
- PT11A - Área Metropolitana do Porto
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- FRESENIUS KABI PHARMA PORTUGAL · Tax ID 504293753
Values and timeline
- Contract price
- €3,602.28
- Procedure base price
- €3,602.28
- Total effective price
- Not reported on Portal BASE
- Publication date
- 24 April 2024
- Award date
- 12 March 2024
- Signing date
- 12 March 2024
- Performance period
- 20 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Monofator
- CPV code
- 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
- Legal basis
- Artigo 24.º, n.º 1, alínea c) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7019269
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.